NCT04524728View on ClinicalTrials.gov

Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy

CompletedOBSERVATIONAL
Enrollment

191

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 30, 2019

Study Completion Date

June 30, 2020

Conditions
BreastNeoplasm MalignantFemale
Interventions
DRUG

Palbociclib

tablets

DRUG

Letrozole 2.5mg

tablets

DRUG

Fulvestrant

intramuscolar injections

Trial Locations (1)

27100

Istituti Clinici Scientifici Maugeri IRCCS, Pavia

All Listed Sponsors
lead

Istituti Clinici Scientifici Maugeri SpA

OTHER

NCT04524728 - Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy | Biotech Hunter | Biotech Hunter